PT  - JOURNAL ARTICLE
AU  - Nijboer, Tanja C.
AU  - Hessel, Ellen V.S.
AU  - van Haaften, Gijs W.
AU  - van Zandvoort, Martine J.
AU  - van der Spek, Peter J.
AU  - Troelstra, Christine
AU  - Kovel, Carolien de
AU  - Koeleman, Bobby P.C.
AU  - van der Zwaag, Bert
AU  - Brilstra, Eva H.
AU  - Burbach, J. Peter H.
TI  - Identification of candidate genes for developmental colour agnosia in a single unique family
AID  - 10.1101/2021.10.01.21263387
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.10.01.21263387
4099  - http://medrxiv.org/content/early/2021/10/01/2021.10.01.21263387.short
4100  - http://medrxiv.org/content/early/2021/10/01/2021.10.01.21263387.full
AB  - Colour agnosia is a disorder that impairs colour knowledge (naming, recognition) despite intact colour perception. Previously, we have identified the first and only-known family with hereditary developmental colour agnosia. The aim of the current study was to explore genomic regions and candidate genes that potentially cause this trait in this family. For three family members with developmental colour agnosia and three unaffected family members CGH-array analysis and exome sequencing was performed, and linkage analysis was carried out using DominantMapper, resulting in the identification of 19 cosegregating chromosomal regions. Whole exome sequencing resulted in 11 rare coding variants present in all affected family members with developmental colour agnosia and absent in unaffected members. These variants affected genes that have been implicated in neural processes and functions (CACNA2D4, DDX25, GRINA, MYO15A), that have a indirect link to brain function or development (MAML2, STAU1, TMED3), and a remaining group lacking brain expression or involved in non-neural traits (DEPDC7, OR1J1, OR8D4, RABEPK). Although this is an explorative study, the small set of candidate genes that could serve as a starting point for unravelling mechanisms of higher level cognitive functions and cortical specialization, and disorders therein such as developmental colour agnosia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by institutional funds and the Focus & Massa Programme of the Utrecht University, the NetherlandsAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UMC Utrecht Medical Ethical CommitteeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be obtained from the first authors upon request